Quidel Corp. announced on March 22 that it received clearance from the Food and Drug Administration for its Quidel Molecular Influenza A+B Assay for the detection of influenza A and B for use with Cepheid’s SmartCycler PCR system.

Quidel received FDA clearance in December to run its Quidel Molecular Influenza A+B and hMPV assays on Life Technologies’ Applied Biosystems 7500 Fast DX thermocycler.